5-Bromo-1-butyl-3-(piperidin-1-ylmethyl)-1H-indole

ID: ALA4578159

Chembl Id: CHEMBL4578159

PubChem CID: 132510886

Max Phase: Preclinical

Molecular Formula: C18H25BrN2

Molecular Weight: 349.32

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCn1cc(CN2CCCCC2)c2cc(Br)ccc21

Standard InChI:  InChI=1S/C18H25BrN2/c1-2-3-11-21-14-15(13-20-9-5-4-6-10-20)17-12-16(19)7-8-18(17)21/h7-8,12,14H,2-6,9-11,13H2,1H3

Standard InChI Key:  MNDUZCSWXWDMGB-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4578159

    ---

Associated Targets(Human)

CACNA1H Tclin Voltage-gated calcium channel (146 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SH-SY5Y (11521 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cortical neurone (598 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 349.32Molecular Weight (Monoisotopic): 348.1201AlogP: 5.19#Rotatable Bonds: 5
Polar Surface Area: 8.17Molecular Species: NEUTRALHBA: 2HBD:
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 7.71CX LogP: 5.18CX LogD: 4.70
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.72Np Likeness Score: -1.57

References

1. Lajarín-Cuesta R, Nanclares C, Arranz-Tagarro JA, González-Lafuente L, Arribas RL, Araujo de Brito M, Gandía L, de Los Ríos C..  (2016)  Gramine Derivatives Targeting Ca(2+) Channels and Ser/Thr Phosphatases: A New Dual Strategy for the Treatment of Neurodegenerative Diseases.,  59  (13): [PMID:27280380] [10.1021/acs.jmedchem.6b00478]

Source